Ian Karp
Public Communications Contact at INTELLIA THERAPEUTICS, INC.
Profile
Ian Karp is currently the Senior Vice President-Corporate Communications at Intellia Therapeutics, Inc. He previously worked as the Senior Director-Global Marketing at Medimmune, Inc. and as the Vice President & Head-Investor Relations at Shire Plc.
He also served as the Senior Vice President-Investor & Public Relations at Karyopharm Therapeutics, Inc. Mr. Karp received his undergraduate degree from Emory University and his MBA from Rutgers Business School.
Ian Karp active positions
| Companies | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - |
Former positions of Ian Karp
| Companies | Position | End |
|---|---|---|
| SHIRE | Investor Relations Contact | 2017-11-30 |
| Medimmune, Inc. | Sales & Marketing | - |
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | - |
Training of Ian Karp
| Emory University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Stock Market
- Insiders
- Ian Karp
